Basic Tofranil Information

• INN (International Nonproprietary Name): Imipramine
• Brand Names Available In Canada (English): not specified
• ATC Code: N06AA02
• Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg (imipramine hydrochloride); Capsules 75 mg, 100 mg, 125 mg, 150 mg (imipramine pamoate)
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription Only (Rx) in all major markets

Latest Research Highlights

Worried whether older drugs like imipramine still work for difficult depression or bedwetting?

International systematic reviews from 2022–2025 continue to show imipramine is effective in treatment‑resistant depression and childhood nocturnal enuresis.

Those reviews also report higher anticholinergic and cardiovascular adverse‑event rates compared with SSRIs and SNRIs.

Canadian randomized controlled trials in recent years are sparse, so most Canada‑specific insight comes from observational clinic data and provincial prescribing patterns.

Clinics in Canada report selective use of imipramine for resistant adult depression and short courses for paediatric enuresis when behavioural measures fail.

Pharmacokinetic updates confirm peak blood levels occur about 2–6 hours after dosing and the long half‑life supports once‑ or twice‑daily dosing.

Relevant meta‑analyses recommend ECG monitoring in older adults and dose caution for patients with hepatic or renal impairment.

• Insert a table summarizing 2022–2025 RCTs versus observational studies where space allows.
• Add a highlighted data block showing comparative adverse‑event rates (anticholinergic, cardiovascular).
• List research gaps: more Canadian RCTs, safety data in Indigenous and rural populations, paediatric long‑term outcomes.

Practical note for pharmacists: when patients mention Tofranil or generic imipramine, explain both benefit and safety profiles clearly in bilingual counselling materials.

Clinical Effectiveness In Canada

Are clinicians in Canada still prescribing imipramine and when is it chosen?

Clinical reviews show imipramine is effective for major depressive disorder and nocturnal enuresis but is generally not first‑line because of its side‑effect burden.

Health Canada classifies imipramine as prescription‑only and product monographs advise baseline cardiac assessment for higher doses and for older adults.

ATC classification is N06AA02, and standard adult dosing often begins at about 75 mg/day divided, titrating upward as tolerated.

Provincial formularies vary: some list generic imipramine with restrictions while others favour newer antidepressants as preferred agents.

In everyday practice, Canadian prescribers balance efficacy with universal‑care priorities such as safety monitoring, follow‑up availability, and cost control on plans like ODB, BC PharmaCare and RAMQ.

• Approved Indications Vs Practical Use: depression and nocturnal enuresis approved; in practice often reserved for resistant cases or short enuresis courses.
• Monitoring Steps: baseline ECG for older adults or higher doses, renal and hepatic function tests as indicated, orthostatic vital checks after initiation.

Rural clinics sometimes keep TCAs in stock because older generics are cost‑effective and familiar for staff when newer agents are not available locally.

Indications And Expanded Uses

Would imipramine be considered for anything beyond depression and bedwetting?

Internationally approved indications include major depressive disorder in adults and childhood nocturnal enuresis.

Off‑label uses reported in the literature include neuropathic pain and panic disorder for refractory cases, but these uses require clear clinical justification and informed consent in Canada.

Standard dosing for enuresis normally starts low at bedtime and is used short‑term, often 1–3 months with drug‑free intervals to reassess need.

• Approved Uses: Major depressive disorder (adult), childhood nocturnal enuresis.
• Off‑Label Uses: Neuropathic pain, panic disorder in treatment‑resistant patients (document rationale).

Paediatric dosing is conservative: typical starting bedtime doses are 10–25 mg with age‑appropriate maximums (50 mg for ages 6–12; up to 75 mg for older adolescents).

When prescribing off‑label in Canada, clinicians usually record the reason to support formulary coverage and to clarify follow‑up expectations with families.

Composition And Brand Landscape

What exactly is in each tablet or capsule and who makes it?

The active ingredient is imipramine, commonly supplied as imipramine hydrochloride or imipramine pamoate depending on formulation.

Tofranil® is the originator brand known in many markets, and Tofranil PM™ appears in US capsule formulations.

Most markets, including Canadian retail channels, are supplied primarily by generic imipramine hydrochloride or pamoate from multiple manufacturers.

Dosage forms commonly available are tablets in 10 mg, 25 mg and 50 mg strengths and pamoate capsules ranging to 150 mg for some markets.

• Novartis is the originator manufacturer associated with the Tofranil brand; generic makers include large distributors such as Teva, Mylan and Sandoz in global markets.
• In Canadian pharmacies (Shoppers Drug Mart, Rexall, Jean Coutu, London Drugs), generics typically predominate for cost reasons; always check the DIN on packaging.

Pharmacists should offer the DIN and bilingual labelling checks for patients and keep a manufacturer list handy when patients ask about Tofranil versus imipramine generic options.

Contraindications And Special Precautions

Who should never take imipramine and what checks are essential?

Absolute contraindications include known hypersensitivity to tricyclic antidepressants, recent myocardial infarction or serious cardiac rhythm disorders, and concurrent use with monoamine oxidase inhibitors (MAOIs).

Relative contraindications that require close monitoring include significant cardiac disease, seizure disorders, narrow‑angle glaucoma, urinary retention or prostatic hypertrophy, and severe liver or kidney impairment.

International guidance and product monographs highlight the need for ECGs before high doses and caution in polypharmacy because of additive cardiac or anticholinergic effects.

• Absolute Contraindications: hypersensitivity to TCAs, recent MI, MAOI co‑use.
• Relative Contraindications: cardiac disease, seizure history, glaucoma, urinary retention, hepatic/renal impairment.

Overdose risk is significant with TCAs and can lead to seizures and life‑threatening arrhythmias, so emergency services must be contacted immediately in suspected cases.

For remote or Indigenous communities with limited ECG access, plan telemedicine assessments or mobile services to ensure safe initiation and monitoring.

Dosage Guidelines

How is dosing started and adjusted for different ages and conditions?

For adult depression, typical initiation is around 75 mg/day divided between morning and evening, titrating up as tolerated toward 150–200 mg/day, with 300 mg/day as a maximum in severe cases.

For paediatric nocturnal enuresis, bedtime doses usually begin at 10–25 mg and may increase to age‑based maximums: 50 mg for 6–12 years and up to 75 mg for older adolescents.

Elderly patients require lower starting doses, often 10–25 mg/day, and cautious titration because of increased sensitivity and fall risk from orthostatic hypotension.

• Start, Therapeutic, Maximum Doses By Group: include adult start ~75 mg/day; therapeutic 150–200 mg; max 300 mg. Paediatric bedtime 10–25 mg start, max 50–75 mg by age.
• Adjustments: lower doses and closer monitoring in renal/hepatic impairment and in the elderly.

Provide clear bilingual dosing instructions and missed‑dose advice: take as soon as remembered unless near the next dose and do not double the next dose.

Interactions Overview

What common drug and lifestyle interactions should be checked at the pharmacy counter?

Major dangerous interactions include concomitant MAOI therapy, which is contraindicated, and combining imipramine with other serotonergic agents that increase serotonin‑syndrome risk.

Other important interactions are with QT‑prolonging drugs, antihypertensives (which may worsen orthostatic hypotension), alcohol (increased CNS depression), and many CYP‑mediated metabolism interactions.

• High‑Risk Interactions: MAOIs (contraindicated), other serotonergic drugs, QT‑prolonging medicines.
• Common OTC Risks: first‑generation antihistamines and some cold medicines add anticholinergic burden and sedation.

Pharmacists should screen for OTC cough, cold and allergy products at pick‑up and advise bilingual counselling when seniors or polypharmacy patients collect imipramine tablets or Tofranil packaging.

Cultural Perceptions And Patient Habits

Do Canadian patients accept a tricyclic antidepressant when newer drugs exist?

Survey and forum feedback in Canada show mixed views: some patients value imipramine for its efficacy in treatment‑resistant cases, while many worry about anticholinergic side effects and fall risk.

Indigenous health services stress culturally safe counselling and involving family or community supports in treatment decisions for mental health and paediatric enuresis care.

Universal healthcare expectations in Canada amplify the need for documented safety follow‑up, cost‑effective choices, and bilingual materials in provinces such as Quebec and New Brunswick.

• Common Patient Concerns: dry mouth, drowsiness, weight change, blurred vision and cardiac safety on higher doses.
• Practical Habits: rural patients often prefer once‑daily dosing to simplify adherence; urban patients may accept closer specialist follow‑up.

Pharmacists in chains like Jean Coutu, Shoppers Drug Mart and Rexall play a critical role in counselling on imipramine tablets, options for generics, and when to refer for ECG or prescriber review.

Availability And Pricing Patterns

How easy is it to get Tofranil or imipramine in Canada and what will it cost?

Supply is dominated by generics internationally and in Canadian retail channels; brand Tofranil remains available in some markets but may be less common on Canadian shelves.

Imipramine is generally available through retail pharmacies and online pharmacy platforms in Canada, with prices and coverage influenced by provincial drug plans and private insurance.

Provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ may list imipramine with specific listing rules or restrictions for coverage.

• Tips For Cost Savings: ask for imipramine generic, check provincial claims, and confirm local pharmacy stock before travelling from rural areas.
• Cross‑Border Notes: some U.S. retailers show lower sticker prices but import rules and prescription requirements apply.

In our online pharmacy, tofranil is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Comparable Medicines And Preferences

What are the alternatives to imipramine and why might a clinician choose them?

Comparable tricyclics include amitriptyline, nortriptyline, desipramine and clomipramine, each with slightly different side‑effect patterns and clinical niches.

SSRIs such as fluoxetine and sertraline are commonly preferred first‑line options for many depressive presentations because of a more favourable tolerability profile.

Clinicians in Canada sometimes favour nortriptyline in older adults for its relatively lower anticholinergic burden compared with imipramine and amitriptyline.

• Pros/Cons Checklist: imipramine—effective in resistant depression and enuresis but higher anticholinergic and cardiac risk; SSRIs—better tolerability but may be less effective in some refractory cases.
• Formulary Preference: provincial plans often list amitriptyline or nortriptyline for off‑label neuropathic pain due to cost and established use.

When counselling, highlight tradeoffs and ensure any switch is done with appropriate tapering and monitoring for withdrawal or recurrence of symptoms.

FAQ Section

What are the short answers patients ask most about imipramine and Tofranil in Canada?

• Is imipramine covered by provincial plans?

  Coverage varies by province and plan; check Ontario Drug Benefit, BC PharmaCare or RAMQ and request the imipramine generic when possible for cost savings.

• What monitoring is needed?

  Baseline ECG for cardiac risk when starting higher doses or for older adults, periodic follow‑up for side effects, and checks on orthostatic vitals after initiation.

• Can children use it for bedwetting?

  Yes, in select cases with short‑term regimens and close follow‑up; typical bedtime starting doses are 10–25 mg with age‑based maximums.

• What should I do in case of overdose?

  Overdose is a medical emergency with risk of seizures and arrhythmias; call emergency services immediately and seek urgent hospital assessment.

Emergency Steps Data Highlight: if an overdose is suspected, do not wait—call 911, bring medication packaging, and inform responders of the exact product name such as Tofranil or imipramine hydrochloride tablets.

Guidelines For Proper Use

How should patients start, monitor and stop imipramine safely?

Best practices recommend a start‑low titration approach, ECG for higher doses and older adults, dose reductions for renal or hepatic impairment, and absolute avoidance with MAOIs.

Discontinuation should be gradual to prevent withdrawal symptoms; abrupt stopping is not advised.

• Initiation Checklist: confirm indication, baseline ECG if indicated, review concurrent meds for interactions, advise on anticholinergic side effects and orthostatic precautions.
• Monitoring Checklist: periodic follow‑up within 1–2 weeks of starting, orthostatic vitals, review for dizziness or urinary retention, and arrange ECGs where needed.

Pharmacists at major chains should document DINs, provide bilingual counselling, offer pill organisers for seniors, and arrange telehealth follow‑ups for remote patients when ECGs or bloodwork are difficult to access.

Emergency Instructions Table Suggestion: include immediate actions for suspected overdose, seizure management and cardiac monitoring pathways in local emergency departments.

Delivery Across Canada (English)